ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

72 hedge funds and large institutions have $44.8M invested in Adamas Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-7
Holders Change %
-8.86%
% of All Funds
1.59%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
9
Increased
24
Reduced
28
Closed
13
Calls
$584K
Puts
$51K
Net Calls
+$533K
Net Calls Change
-$427K
Name Holding Trade Value Shares
Change
Shares
Change %
Squarepoint
76
Squarepoint
New York
-$114K -30,177 Closed
JG
77
Jefferies Group
New York
-$107K -28,135 Closed
Jane Street
78
Jane Street
New York
-$79K -20,918 Closed
BGIM
79
Brandywine Global Investment Management
Pennsylvania
-$70K -17,127 Closed
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$54K -14,336 Closed
HF
81
HRT Financial
New York
-$43K -11,432 Closed
PP
82
Paloma Partners
Connecticut
-$39K -10,239 Closed
CHAM
83
Clear Harbor Asset Management
Connecticut
-$18.6K -4,920 Closed
Bank of Montreal
84
Bank of Montreal
Ontario, Canada
-$11K -2,811 Closed
Fidelity Investments
85
Fidelity Investments
Massachusetts
-$1K -300 Closed